Skip to main content Search Search people, articles, bills, and more
Hearing Recap: “Profits Over Patients: The PBM Business Model Under Scrutiny” — Burgess Owens | ChamberLight
SOURCE CHECK TAP FOR WHY Not enough stories yet: 6 of 10.
This article 1 analysis · Apr 23, 2026
100 Credibility Source credibility: 100 out of 100, high 40 Neutrality Story neutrality: 40 out of 100, one-sided RIGHT LEAN Right
The House Subcommittee on Health, Employment, Labor, and Pensions held a hearing to examine how pharmacy benefit managers (PBMs) contribute to rising drug costs and lack of transparency.
Community verdict 9 VOTES How does this story look for
● OPEN ▲ GOOD LOOK TAP TO VOTE 86% TAP TO VOTE ▼ BAD LOOK TAP TO VOTE 14% TAP TO VOTE
Doesn't really affect Foxx Rated by people, not pundits. ● OPEN
People in this story SWIPE → Discussion · 0 best newest discussed
best Not enough stories yet: 6 of 10.
This article 1 analysis · Apr 23, 2026
100 Credibility HIGH Source credibility: 100 out of 100 40 Neutrality ONE-SIDED Story neutrality: 40 out of 100
POLITICAL LEAN Right
People in this story 4 Committee member questioning witnesses
PRIMARY SUBJECT
From the source ChamberLight summarizes and scores Committee on Education & the Workforce's reporting. The full story is on Committee on Education & the Workforce.
Read original article 
